119-hr1806

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1806 Introduced in House

    (IH) ]

<DOC>

119th CONGRESS
 1st Session
 H. R. 1806

 To provide for research and education with respect to triple-negative 
 breast cancer, and for other purposes.

_______________________________________________________________________

 IN THE HOUSE OF REPRESENTATIVES

 March 3, 2025

Mr. Morelle (for himself and Mr. Bacon) introduced the following bill; 
 which was referred to the Committee on Energy and Commerce

_______________________________________________________________________

 A BILL

 To provide for research and education with respect to triple-negative 
 breast cancer, and for other purposes.

 Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

 This Act may be cited as the ``Triple-Negative Breast Cancer 
Research and Education Act of 2025''.

SEC. 2. FINDINGS.

 Congress finds as follows:

    (1) Breast cancer accounts for 1 in 4 cancer diagnoses 
 among women in this country.

    (2) The survival rate for breast cancer has increased to 90 
 percent for White women and 78 percent for African-American 
 women.

    (3) African-American women are more likely to be diagnosed 
 with larger tumors and more advanced stages of breast cancer 
 despite a lower incidence rate.

    (4) Early detection for breast cancer increases survival 
 rates for breast cancer, as evidenced by a 5-year relative 
 survival rate of 98 percent for breast cancers that are 
 discovered before the cancer spreads beyond the breast, 
 compared to 23 percent for stage IV breast cancers.

    (5) Triple-negative breast cancer is a term used to 
 describe breast cancers whose cells do not have estrogen 
 receptors and progesterone receptors, and do not have an excess 
 of the HER2 protein on their sources.

    (6) It is estimated that between 10 and 20 percent of 
 female breast cancer patients are diagnosed with triple-
 negative breast cancer, and studies indicate the prevalence of 
 triple-negative breast cancer is much higher.

    (7) Triple-negative breast cancer most commonly affects 
 African-American women, followed by Hispanic women.

    (8) Triple-negative breast cancer is a very aggressive form 
 of cancer which affects women under the age of 50 across all 
 racial and socioeconomic backgrounds.

    (9) African-American women are 3 times more likely to 
 develop triple-negative breast cancer than White women.

    (10) Triple-negative breast cancer tends to grow and spread 
 more quickly than most other types of breast cancer.

    (11) Like other forms of breast cancer, triple-negative 
 breast cancer is treated with surgery, radiation therapy, or 
 chemotherapy.

    (12) Early-stage detection of triple-negative breast cancer 
 is the key to survival because the tumor cells lack certain 
 receptors, and neither hormone therapy nor drugs that target 
 these receptors are effective against these cancers; therefore, 
 early detection and education is vital.

    (13) Current research and available data do not provide 
 adequate information on--
        (A) the rates of prevalence and incidence of 
 triple-negative breast cancer in African-American, 
 Hispanic, and other minority women;
        (B) the costs associated with treating triple-
 negative breast cancer; and
            (C) the methods by which triple-negative breast 
 cancer may be prevented or cured in these women.

SEC. 3. TRIPLE-NEGATIVE BREAST CANCER.

 Subpart I of part C of title IV of the Public Health Service Act 
(42 U.S.C. 285 et seq.) is amended by inserting after 

section 417A (42 
U.S.C. 285a-7) the following:

``

SEC. 417B. TRIPLE-NEGATIVE BREAST CANCER.

 ``

    (a) Research.--
 ``

    (1) In general.--The Director of the National Institutes 
 of Health (in this section referred to as the `Director of 
 NIH') shall expand, intensify, and coordinate programs for the 
 conduct and support of research with respect to triple-negative 
 breast cancer.
 ``

    (2) Administration.--The Director of NIH shall carry out 
 this subsection through the appropriate institutes, offices, 
 and centers of the National Institutes of Health, including the 
 Eunice Kennedy Shriver National Institute of Child Health and 
 Human Development, the National Institute of Environmental 
 Health Sciences, the Office of Research on Women's Health, and 
 the National Institute on Minority Health and Health 
 Disparities.
 ``

    (3) Coordination of activities.--The Director of the 
 Office of Research on Women's Health shall coordinate 
 activities under this subsection among the institutes, offices, 
 and centers of the National Institutes of Health.
 ``

    (4) Authorization of appropriations.--For the purposes of 
 carrying out this subsection, there are authorized to be 
 appropriated such sums as may be necessary for each of the 
 fiscal years 2026 through 2031.
 ``

    (b) Education and Dissemination of Information With Respect to 
Triple-Negative Breast Cancer.--
 ``

    (1) Triple-negative breast cancer public education 
 program.--The Secretary of Health and Human Services, acting 
 through the Director of the Centers for Disease Control and 
 Prevention, shall develop and disseminate to the public 
 information regarding triple-negative breast cancer, including 
 information on--
 ``
        (A) the incidence and prevalence of triple-
 negative breast cancer among women;
 ``
        (B) the elevated risk for minority women to 
 develop triple-negative breast cancer; and
 ``
            (C) the availability, as medically appropriate, 
 of a range of treatment options for symptomatic triple-
 negative breast cancer.
 ``

    (2) Dissemination of information.--The Secretary may 
 disseminate information under paragraph

    (1) directly or through 
 arrangements with nonprofit organizations, consumer groups, 
 institutions of higher education, Federal, State, or local 
 agencies, or the media.
 ``

    (3) Authorization of appropriations.--For the purpose of 
 carrying out this subsection, there are authorized to be 
 appropriated such sums as may be necessary for each of the 
 fiscal years 2026 through 2031.
 ``
            (c) Information to Health Care Providers With Respect to Triple-
Negative Breast Cancer.--
 ``

    (1) Dissemination of information.--The Secretary of 
 Health and Human Services, acting through the Administrator of 
 the Health Resources and Services Administration, shall develop 
 and disseminate to health care providers information on triple-
 negative breast cancer for the purpose of ensuring that health 
 care providers remain informed about current information on 
 triple-negative breast cancer. Such information shall include 
 the elevated risk for minority women to develop triple-negative 
 breast cancer and the range of available options for the 
 treatment of symptomatic triple-negative breast cancer.
 ``

    (2) Authorization of appropriations.--For the purpose of 
 carrying out this subsection, there are authorized to be 
 appropriated such sums as may be necessary for each of the 
 fiscal years 2026 through 2031.
 ``
            (d) === Definition. ===
-In this section, the term `minority women' means 
women who are members of a racial and ethnic minority group, as defined 
in 

section 1707

    (g) .''.
 <all>